መነሻ › የስራ አስፈጻሚዎች › Pharmacist-in-Charge
Pharmacist-in-Charge፡ የH-1B ደመወዞች
89 የሥራ ሁኔታ ማመልከቻዎች የሥራ መደብ Pharmacist-in-Charge ተጠቅመዋል። መካከለኛ የቀረበ መሠረታዊ ደመወዝ $124,800፤ መካከለኛ ግማሽ $119,827–$139,360።
ማመልከቻዎች (LCAs)89
መካከለኛ የሚቀርብ ደመወዝ$124,800
የደመወዞች መካከለኛ ግማሽ$119,827–$139,360
ከ10ኛ እስከ 90ኛ ፐርሰንታይል$113,121–$155,300
የእርዳታ ደረጃዎችን ወይም የሥራ ቦታዎችን ያግኙ — $99 ለ30 ቀናት →
አሠሪዎች
| አሠሪ | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| RX Professionals LLC | 4 | $113,464 |
| GS Pharmacy LLC | 3 | $120,640 |
| dMb Health at Corpus LLC | 3 | $115,000 |
| Long Lane Discount Pharmacy LLC | 3 | $124,800 |
| Maa Bhawani Inc. | 3 | $139,360 |
| ReShape Rx, LLC | 3 | $130,000 |
| Assure RX Pharmacy LLC | 2 | $117,250 |
| Rapid RX Pharmacy LLC | 2 | $130,700 |
| GMK Pharmacy Inc. | 2 | $140,000 |
| RX Express Pharmacy LLC | 2 | $106,658 |
| Texas State Pharmacy LLC | 2 | $123,280 |
| Mahant RX Inc. | 2 | $152,500 |
| Branch Brook Corp | 2 | $119,309 |
| PALISADE Ave Pharmacy LLC | 2 | $116,667 |
| American Star Pharmacy Inc. | 2 | $139,360 |
| Reliance Imperial Pharmacy LLC | 2 | $156,000 |
| Sai Bear Creek Pharmacy LLC | 2 | $161,598 |
| Carenow Pharmacy II LLC | 1 | $128,700 |
| Pharmore RX Inc. | 1 | $114,962 |
| Greenhill Pharmacy Corporation | 1 | $108,160 |
| Hillrise Pharmacy LLC | 1 | $120,000 |
| EMA Healthcare, Inc | 1 | $135,200 |
| MPN2 Pharmacy Mgt LLC | 1 | $117,000 |
| Atmaca LLC ( Our Pharmacy) | 1 | $105,600 |
| Ravkoo, Inc. | 1 | $135,200 |
| Shivsai RX, LLC d/b/a Sanford Discount Pharmacy | 1 | $124,800 |
| Kevin Concannon LLC | 1 | $133,120 |
| Pomp Rx Pharmacy LLC | 1 | $124,800 |
| Superfast Pharmacy and Medical Supplies, LLC | 1 | $125,000 |
| Maa Bhavani Inc | 1 | $135,200 |
| BJP Healthcare LLC | 1 | $135,200 |
| Tampa Pharmacy 13 LLC | 1 | $135,200 |
| Medshop Pharmacy LLC | 1 | $155,000 |
| Laurel Health Services Inc | 1 | $130,628 |
| Marra's Pharma Corp | 1 | $150,000 |
| Williams Drug LLC | 1 | $162,240 |
| Rajhans Inc. | 1 | $108,160 |
| Crown Point Pharmacy LLC | 1 | $114,400 |
| Columbia RX LLC | 1 | $1,560,000 |
| Prasanna LLC | 1 | $120,640 |
| Ocean Blue Holdings LLC | 1 | $124,800 |
| Crawford Pharmacy of Pleasanton | 1 | $128,960 |
| Lifecare Pharmacy LTC LLC | 1 | $130,000 |
| Bcrr RX Inc. | 1 | $132,000 |
| Centreville Drugs Inc. | 1 | $124,800 |
| ReShape Rx Houston LLC | 1 | $130,000 |
| Blue Pharmacy LLC | 1 | $120,000 |
| MPN Pharmacy MGT LLC. | 1 | $140,000 |
| Shreeji RX LLC | 1 | $124,800 |
| Dhanvis Health Care-2 LLC | 1 | $110,000 |
| Piedment Family Pharmacy LLC | 1 | $120,000 |
| Univv II Inc | 1 | $120,640 |
| PSM MSM 100 LLC | 1 | $165,000 |
| Drugs Cure Pharmacy & Surgicals LLC | 1 | $124,800 |
| Akshaya Sai LLC. | 1 | $120,000 |
| Sai Geeta Drug LLC | 1 | $120,000 |
| Venkateswara Pharmacy Inc | 1 | $175,000 |
| Hancock Pharmacy II LLC | 1 | $145,600 |
| LC Pharma of Uvalde, LLC | 1 | $135,200 |
| Basin RX LLC | 1 | $165,000 |
በደመወዝ ደረጃ
| የደመወዝ ደረጃ | መካከለኛ ደመወዝ |
|---|---|
| ደረጃ I (መግቢያ) | $110,240 |
| ደረጃ II (ብቁ) | $124,800 |
| ደረጃ III (ልምድ ያለው) | $155,500 |
| ደረጃ IV (ሙሉ ብቃት ያለው) | $152,500 |
የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።
በፊስካል ዓመት
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2023 | 29 | $120,640 |
| FY2024 | 12 | $125,507 |
| FY2025 | 29 | $130,000 |
| FY2026 | 18 | $131,600 |
ከተሞች
- San Antonio, TX8
- Dallas, TX6
- Beverly Hills, FL4
- Brooklyn, NY3
- Paterson, NJ3
- Corpus Christi, TX3
- Upper Darby, PA3
- New Braunfels, TX3
- Bronx, NY2
- Allentown, PA2
- Westland, MI2
- Belle Glade, FL2
- Newark, NJ2
- Jersey City, NJ2
- Houston, TX2
- El Centro, CA2
- Andrews, TX2
- Wildomar, CA2
- Mount Dora, FL1
- Parsippany, NJ1
- Las Cruces, NM1
- Gardena, CA1
- Lakeway, TX1
- Burlington, NJ1
- Auburndale, FL1
- Sanford, FL1
- Edinburg, TX1
- Pompano Beach, FL1
- Tomball, TX1
- Lockhart, TX1
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።